Skip to main content
. 2015 Feb 2;6(3):1740–1749. doi: 10.18632/oncotarget.2714

Figure 2. Gemcitabine-resistant (GR) cells have enhanced motility activity.

Figure 2

(A) Left panel: migration assay was performed in parental and GR cells. Right panel: Quantitative results are illustrated for left panel. *P < 0.05 vs control. (B) Wound assays were performed in parental and GR cells. (C) Cell attachment and attachment assays were assessed in parental and GR cells. *P < 0.05 vs control.